A citation-based method for searching scientific literature

Xiao-Xi Zhang, Yan-Hong Pan, Yan-Mei Huang, Hai-Lu Zhao. World J Diabetes 2016
Times Cited: 21







List of co-cited articles
138 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.
G J Cooper, A C Willis, A Clark, R C Turner, R B Sim, K B Reid. Proc Natl Acad Sci U S A 1987
825
33

Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
Per Westermark, Arne Andersson, Gunilla T Westermark. Physiol Rev 2011
522
33

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.
Seth L Masters, Aisling Dunne, Shoba L Subramanian, Rebecca L Hull, Gillian M Tannahill, Fiona A Sharp, Christine Becker, Luigi Franchi, Eiji Yoshihara, Zhe Chen,[...]. Nat Immunol 2010
776
23

Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis.
Leena Haataja, Tatyana Gurlo, Chang J Huang, Peter C Butler. Endocr Rev 2008
375
23

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus.
A Lorenzo, B Razzaboni, G C Weir, B A Yankner. Nature 1994
554
23


Dose-response for glucagonostatic effect of amylin in rats.
B R Gedulin, T J Rink, A A Young. Metabolism 1997
109
19

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.
Alexandra E Butler, Juliette Janson, Susan Bonner-Weir, Robert Ritzel, Robert A Rizza, Peter C Butler. Diabetes 2003
19


A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas.
P Westermark, C Wernstedt, E Wilander, K Sletten. Biochem Biophys Res Commun 1986
338
14

The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus.
B Nyholm, L Orskov, K Y Hove, C H Gravholt, N Møller, K G Alberti, C Moyses, O Kolterman, O Schmitz. Metabolism 1999
73
14

Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone.
P Westermark, C Wernstedt, T D O'Brien, D W Hayden, K H Johnson. Am J Pathol 1987
185
14

Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle.
G J Cooper, B Leighton, G D Dimitriadis, M Parry-Billings, J M Kowalchuk, K Howland, J B Rothbard, A C Willis, K B Reid. Proc Natl Acad Sci U S A 1988
239
14


Amylin-mediated control of glycemia, energy balance, and cognition.
Elizabeth G Mietlicki-Baase. Physiol Behav 2016
23
14

Amylin: Pharmacology, Physiology, and Clinical Potential.
Debbie L Hay, Steve Chen, Thomas A Lutz, David G Parkes, Jonathan D Roth. Pharmacol Rev 2015
138
14

Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM.
M F Kong, P King, I A Macdonald, T A Stubbs, A C Perkins, P E Blackshaw, C Moyses, R B Tattersall. Diabetologia 1997
84
14

Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets.
Björn Akesson, Georgios Panagiotidis, Per Westermark, Ingmar Lundquist. Regul Pept 2003
46
14



Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR.
Sorin Luca, Wai-Ming Yau, Richard Leapman, Robert Tycko. Biochemistry 2007
406
14

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.
Rakez Kayed, Elizabeth Head, Jennifer L Thompson, Theresa M McIntire, Saskia C Milton, Carl W Cotman, Charles G Glabe. Science 2003
14

Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology.
Rehana Akter, Ping Cao, Harris Noor, Zachary Ridgway, Ling-Hsien Tu, Hui Wang, Amy G Wong, Xiaoxue Zhang, Andisheh Abedini, Ann Marie Schmidt,[...]. J Diabetes Res 2016
97
14

The role of amylin in the control of energy homeostasis.
Thomas A Lutz. Am J Physiol Regul Integr Comp Physiol 2010
87
14


An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing.
T Sanke, G I Bell, C Sample, A H Rubenstein, D F Steiner. J Biol Chem 1988
168
14

The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults.
P Westermark, L Grimelius. Acta Pathol Microbiol Scand A 1973
90
14

Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans.
E Hartter, T Svoboda, B Ludvik, M Schuller, B Lell, E Kuenburg, M Brunnbauer, W Woloszczuk, R Prager. Diabetologia 1991
118
14


Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death.
Lucy Marzban, Christopher J Rhodes, Donald F Steiner, Leena Haataja, Philippe A Halban, C Bruce Verchere. Diabetes 2006
68
14

Amyloidogenic peptide oligomer accumulation in autophagy-deficient β cells induces diabetes.
Jinyoung Kim, Hwanju Cheon, Yeon Taek Jeong, Wenying Quan, Kook Hwan Kim, Jae Min Cho, Yu-Mi Lim, Seung Hoon Oh, Sang-Man Jin, Jae Hyeon Kim,[...]. J Clin Invest 2014
90
14


Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway.
Tatyana Gurlo, Sergey Ryazantsev, Chang-jiang Huang, Michael W Yeh, Howard A Reber, O Joe Hines, Timothy D O'Brien, Charles G Glabe, Peter C Butler. Am J Pathol 2010
138
14


Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
9

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
T Vilsbøll, T Krarup, J Sonne, S Madsbad, A Vølund, A G Juul, J J Holst. J Clin Endocrinol Metab 2003
335
9


Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells.
Hisamitsu Ishihara, Pierre Maechler, Asllan Gjinovci, Pedro-Luis Herrera, Claes B Wollheim. Nat Cell Biol 2003
276
9



Pramlintide improved measures of glycemic control and body weight in patients with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapy.
Kathrin Herrmann, Juan P Frias, Steven V Edelman, Karen Lutz, Kevin Shan, Steven Chen, David Maggs, Orville G Kolterman. Postgrad Med 2013
12
16

Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
S Enoki, T Mitsukawa, J Takemura, M Nakazato, J Aburaya, H Toshimori, S Matsukara. Diabetes Res Clin Pract 1992
72
9

The physiology of glucagon-like peptide 1.
Jens Juul Holst. Physiol Rev 2007
9

Tissue expression and secretion of amylin.
Andrew Young. Adv Pharmacol 2005
38
9

Peripheral oxyntomodulin reduces food intake and body weight gain in rats.
Catherine L Dakin, Caroline J Small, Rachel L Batterham, Nicola M Neary, Mark A Cohen, Michael Patterson, Mohammad A Ghatei, Stephen R Bloom. Endocrinology 2004
207
9


Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial.
Katie Wynne, Adrian J Park, Caroline J Small, Michael Patterson, Sandra M Ellis, Kevin G Murphy, Alison M Wren, Gary S Frost, Karim Meeran, Mohammad A Ghatei,[...]. Diabetes 2005
243
9

Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells.
S E Kahn, D A D'Alessio, M W Schwartz, W Y Fujimoto, J W Ensinck, G J Taborsky, D Porte. Diabetes 1990
286
9

Fibroblast growth factor 21 corrects obesity in mice.
Tamer Coskun, Holly A Bina, Michael A Schneider, James D Dunbar, Charlie C Hu, Yanyun Chen, David E Moller, Alexei Kharitonenkov. Endocrinology 2008
643
9

Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes.
Stuart A Weinzimer, Jennifer L Sherr, Eda Cengiz, Grace Kim, Jessica L Ruiz, Lori Carria, Gayane Voskanyan, Anirban Roy, William V Tamborlane. Diabetes Care 2012
81
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.